A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors. (Q53253771)
Jump to navigation
Jump to search
scientific article published on 24 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors. |
scientific article published on 24 October 2014 |
Statements
A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors. (English)
1 reference
A W Tolcher
1 reference
J C Bendell
1 reference
K P Papadopoulos
1 reference
H A Burris
1 reference
A Patnaik
1 reference
S F Jones
1 reference
D Rasco
1 reference
D S Cox
1 reference
M Durante
1 reference
K M Bellew
1 reference
J Park
1 reference
N T Le
1 reference
J R Infante
1 reference
24 October 2014
1 reference
26
1 reference
1
1 reference
58-64
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference